Our Team


Investment Team

Antony Leung

Group Chairman & Co-Founder

“In New Frontier, we have a young but proven team solving some of the biggest challenges of our time, right here in Asia.”

Mr. Antony Leung is the Co-founder and Group Chairman of New Frontier Group.

Antony is also Group Chairman & CEO of Nan Fung Group, a regional conglomerate engaging in real estate and investment businesses. Prior to this, Antony was Senior Managing Director, Chairman of Greater China and a member of the Executive Committee of Blackstone.

Antony was the Financial Secretary of Hong Kong from 2001 to 2003. Prior to this appointment, Antony had extensive experience in financial services. He was the Chairman of Asia for JP Morgan Chase; Country Corporate Officer of Citigroup for China and Hong Kong, Regional Treasurer for North Asia, Head of Investment Banking for North and South West Asia and Head of Private Banking for Asia.

Other public service that Antony had engaged in included Non-Official Member of the Executive Council of Hong Kong SAR, Chairman of Education Commission, Chairman of University Grants Committee, Member of Exchange Fund Advisory Committee, Director of Hong Kong Airport Authority and Hong Kong Futures Exchange, Member of the Preparatory Committee and Election Committee for the Hong Kong Special Administrative Region and Hong Kong Affairs Advisors.

Antony was Independent Director of Industrial and Commercial Bank of China, China Mobile (Hong Kong) Limited, and American International Assurance (Hong Kong) Limited; Vice Chairman of China National Bluestar Group and International Advisory Board Member of China Development Bank and European Advisory Group.

Antony is currently an Independent Non-Executive Director of China Merchants Bank and Chairman of charity organizations Heifer International Hong Kong and Food Angel.

Carl Wu

Chief Executive Officer & Co-Founder

Mr. Carl Wu is the Co-Founder and CEO of New Frontier Group. Mr. Wu is a healthcare and internet entrepreneur. He is the Executive Chairman and Co-founder of YD Care (home healthcare service provider), Heal (oncology group in the Greater Bay area), Boxful Technology (the leading on-demand storage service provider in Asia), HelloToby Technology (the leading online service marketplace in Hong Kong) and Precision Medical. Carl is also the Chairman of Care Alliance (the leading post-acute healthcare operator in China), Chairman of the Executive Committee of New Frontier Health / United Family Healthcare (NYSE: NFH).

Prior to founding New Frontier, Mr. Wu was one of the youngest Managing Directors at Blackstone and executed some of Blackstone’s most important investments in China. He was a founding member of Blackstone Asia and was instrumental in establishing Blackstone’s businesses across China. Prior to moving to Hong Kong, Mr. Wu was based in Blackstone’s London office. Before joining Blackstone, he worked in investment banking at UBS in London.

Mr. Wu holds a Bachelor of Science in Economics from the London School of Economics, where he graduated with First Class Honors.

Tom Sze

Managing Director

Tom Sze is the Head of Strategic Investments of New Frontier.Prior to joining New Frontier, Tom was an Investment Professional at Viking Global Investors, one of the largest global hedge funds, where he was responsible for a few billion dollars in the Asia Internet, Technology, Media and Telecom, and Industrial sectors. Prior to Viking, Tom was at Blackstone’s Private Equity Group in Hong Kong. He was one of the earlier members of the Blackstone Asia team, where he led and executed a number of investments in China, Korea, South East Asia and Australia. Prior to Hong Kong, Tom worked at Francisco Partners and McKinsey in San Francisco.

Tom received his Bachelor of Science degree in Electrical Engineering and Computer Science with Magna Cum Laude from Harvard University, and a Masters degree in Management Science and Engineering from Stanford University.

David Zeng

Managing Director

David Zeng is a Managing Director at New Frontier Group and is a Director of the Board of New Frontier Health Corporation (NYSE: NFH). Mr. Zeng is primarily responsible for the investments efforts at New Frontier Group and the operations of portfolio companies. Mr. Zeng led the acquisition of United Family Healthcare by New Frontier Corporation (renamed to New Frontier Health Corporation) with a total enterprise valuation of $1.44 billion.

Prior to joining New Frontier, Mr. Zeng was a Senior Associate at Blackstone’s Private Equity Group in Hong Kong. At Blackstone, he executed a number of investments across multiple industries in China, including the take-private of Global Sources Limited (one of world’s largest electronics exhibition operators) and the buyout of Shya Hsin Packaging (one of world’s largest color cosmetics plastic packagers). Mr. Zeng was also actively involved in the operations of Blackstone portfolio companies. He was most recently the interim-CFO and Executive Director of Shya Hsin Packaging and led a number of key operational initiatives. Prior to joining Blackstone, Mr. Zeng was a member of the Mergers & Acquisitions Group at Barclays in Hong Kong.

Harry Chang

Managing Director

Harry Chang is a Managing Director of New Frontier Capital. Harry has extensive experience across private equity, credit and special situation investments in the US, Europe and China. Prior to joining New Frontier, Harry has managed multiple private equity funds including: China- Israel High Tech Fund and Global Cross-Border Buyout Fund for Everbright Limited and Cross-Border CITIC-Kazyna Investment Fund for CITIC Capital.

Prior to China, Harry has over a decade of investment experience in Europe. Based in London, he was a founding member of the Lehman Brothers European Special Situation’s Group covering investments across EMEA. Prior to Europe, Harry was at Merrill Lynch’s Leveraged Finance and High Yield Group in New York.

Harry earned his Bachelor of Science degree from the University of Virginia and a Master of Business Administration from the University of Chicago.

Brian Siu


Brian Siu is an Executive Director of New Frontier.

Brian currently helps with the new project development and ventures portfolio management in New Frontier. Brian works closely with the venture team at New Frontier and is involved in formulating deal terms, structuring and execution of investment opportunities.

Before joining New Frontier, Brian spent 6 years in consulting and VC sector. Brian worked in McKinsey & Company, Greater China first as a Business Analyst and an Associate, covering healthcare, financial, internet, consumer goods, logistics industries, etc. After the time at McKinsey, Brian joined Nova Founders Capital as a Venture Manager to manage over 100Mil HKD yearly digital marketing budget for its major portfolio companies.

Brian earned his Bachelor in Business Administration from the Chinese University of Hong Kong.

Arthur Chen


Mr. Arthur Chen is currently an Investment Associate at New Frontier. Arthur primarily focuses on the sourcing and execution of investment opportunities in healthcare and education industries.Before joining New Frontier, Arthur worked in IDG Capital as a Financial Analyst where he was involved in the post investment financial analysis of hundreds of portfolio companies across the world. Prior to this, he was an Associate in PricewaterhouseCoopers Advisory.

Arthur obtained his Bachelor in Business Administration (Accounting and Finance) from the University of Hong Kong.



Board of Directors

Meng Gao


Mr. Meng Gao is a Partner of New Frontier.

Mr. Meng Gao is also Managing Director of the Group CEO’s Office at Nan Fung Group, a major founding investor of New Frontier. Meng is a representative of Nan Fung on the Board of New Frontier.

Prior to joining Nan Fung, Meng was a Managing Director at Blackstone’s Private Equity Group in Hong Kong. At Blackstone, he was involved in a number of transactions across multiple industries. Before joining Blackstone, Meng was a Senior Vice President at Oaktree Capital Management, where he was involved in sourcing, structuring and executing private equity investments in China. Prior to that, Mr. Gao was an investment banker with Credit Suisse and JPMorgan in New York.

Meng received a Bachelor of Economics degree from Peking University, an M.A. from Yale University and an M.B.A. from the Wharton School of the University of Pennsylvania, where he graduated with Honours.

Carlos Ng


Mr. Carlos Ng is a Partner and the Founding Investor of New Frontier.

Carlos is also the Founding Partner of City Square REI, a regional real estate private equity fund, where he had executed some of the most important Real Estate transactions including Garden Square, a major Grade A skyscraper in the centre of Shanghai. He is the Chief Investment Officer and was instrumental in establishment City Square REI’s Business in Greater China. Carlos is based in Hong Kong and Shanghai. Prior to founding City Square REI, he was also a senior member of DTZ China Investment and Tesco China.

Carlos is also the Founder of Kland Capital, which has invested in different business sectors such as Property Consultant, F&B retail and Healthcare business.

Carlos also serves on the Boards of TingHo Development Group (Ting Hsin’s Real Estate investment vehicle).

Carlos is a member of Royal Institution of Chartered Surveyors (RICS) and He holds a Master’s Degree from King’s College London University.

Hong-chen Wei


Mr. Hong-chen Wei is a Board Member of New Frontier and the Founding Investor of New Frontier and Boxful Technology.

Hong-chen is currently the Executive Director of Master Kong, one of the largest food and beverage companies in Asia. Mr. Wei is also a key leader of TingHsin Group, one of Asia’s largest consumer conglomerate with interests across multiple industries, including Master Kong, FamilyMart China (leading convenience store chain in China), Dicos (the 3rd largest fast food chain in China), Taipei 101 (one of the tallest buildings in the world), Taiwan Star (leading mobile operator in Taiwan), and others.

Before joining Master Kong, Mr. Wei worked at Blackstone’s New York office, PepsiCo Chairperson and CEO office directly under the leadership of Indra Nooyi (PepsiCo Chairperson and CEO) and Asahi Group in Tokyo.

Mr. Wei received his Bachelor degree from Imperial College London, Master’s degree from Waseda University, and MBA from Harvard Business School.

Dr. Leong Che Hung


Edward Leong Che-hung, 79, is a director of New Frontier Corporation. Dr. Leong is one of the most respected medical professionals and public health administrators in Asia, having actively engaged in public services and has engaged in various influential public roles during his career. He was a member of the Legislative Council of Hong Kong, representing the medical constituency from 1988 to 2000. In 2002, Dr. Leong was appointed as the chairman of the Hong Kong Hospital Authority where he was involved in drawing up the blueprint for Hospital Authority, taking special responsibility for Medical Service Development. Subsequently, Dr. Leong served as a non-official member of the Executive Council HKSAR from 2005 to 2012. He was chairman of the Hong Kong University Council until 2015 and spearheaded the commissioning of The University of Hong Kong – Shenzhen Hospital in Shenzhen during his term. Dr. Leong also served as the chairman of the Standard Working Hours Committee. His other former public positions include the Chairman of the Elderly Commission HKSAR, Chairman of Hong Kong AIDS Foundation and the Elder Academy Development Foundation. Dr. Leong was awarded the Gold Bauhinia Star in 2001 and the Grand Bauhinia Medal in 2010.

Dr. Leong is a medical doctor in private practice specializing in urology. After graduating from the University of Hong Kong in 1962, Dr. Leong worked in the Department of Surgery in Hong Kong University for 16 years. In addition to training medical students, Dr. Leong also conducted cutting-edge research in his specialist fields of urology. His major research contributions include experiments and the human use of the stomach for bladder replacement and urinary diversion. Dr. Leong was appointed Hunterian Professor by the Royal College of Surgeons of England in 1975. He was the first Hong Kong-born Chinese doctor to have received this accolade.

Dr. Leong’s qualifications to serve on our board of directors include his extensive network and deep knowledge in the healthcare and education industries and his significant management experience in both the public and private sectors.

Mr. Ma Si-hang, Frederick


Frederick Ma Si-hang, 66, is a director of New Frontier Corporation. Professor Ma is the non-executive chairman of the MTR Corporation. He is currently an independent non-executive director of FWD Group and a director of Husky Energy Inc. Professor Ma was previously an independent non-executive director of Agricultural Bank of China Limited, Aluminum Corporation of China Limited, Hutchison Port Holdings Management Pte. Limited and China Resources Land Limited, and also a non-executive director of China Mobile Communications Corporation and COFCO Corporation. He was a member of Managing Board at Kowloon-Canton Railway Corporation and a director of Airport Authority Hong Kong and the Hong Kong Mortgage Corporation Limited.

Professor Ma has extensive experience in the banking and financial sectors. He started his career at Chase Manhattan Bank in 1973 and returned to Chase Manhattan as Asia-Pacific Managing Director and Area Director of Global Private Bank in 1998. Following the merger of Chase Manhattan and JP Morgan in 2001, Professor Ma was appointed by JP Morgan Private Bank as Asia-Pacific Chief Executive. In 2001, he joined Pacific Century Cyberworks (PCCW) Limited as an Executive Director and was appointed Chief Financial Officer in 2002.

Professor Ma was previously the Secretary for Financial Services and the Treasury of the Hong Kong Special Administrative Region (HKSAR) Government from 2002 to 2007. Professor Ma held the position of the Secretary for Commerce and Economic Development of the HKSAR Government from 2007 to 2008. He is currently a non-official member of the HKSAR Government Chief Executive’s Council of Advisers on Innovation and Strategic Development, a member of the International Advisory Council of China Investment Corporation and the Global Advisory Council of Bank of America. Professor Ma was awarded the Gold Bauhinia Star medal in 2009 and was appointed a Justice of the Peace in 2010.

Besides his corporate and government positions, Professor Ma has also taken various roles in multiple universities in Asia. In 2008, Professor Ma took up an honorary professorship at the School of Economics and Finance at the University of Hong Kong. In August 2013, he was also appointed an Honorary Professor of Business Administration at the Chinese University of Hong Kong. He is currently the Council Chairman of The Education University of Hong Kong.

Professor Ma’s qualifications to serve our board of directors include his over 40 years of public and private sector experience, his deep and extensive financial sector experience his experience as a board member and executive officer of some of the biggest Asian public companies in a variety of industries.

Senior Advisors

Fu Shan
Fu Shan

Shan Fu joined Vivo in 2013 as a Managing Partner, Co-CEO and CEO of China. Before joining Vivo, Mr. Fu worked for Blackstone as Senior Managing Director in the Private Equity group and the Chief Representative of Blackstone’s Beijing Office. Mr. Fu also worked in the Department of Foreign Investment in China’s National Development and Reform Commission (NDRC), the State Economic and Trade Commission of China, the Office of Economic and Trade in State Council of China, and the Office of Production in State Council of China.

Mr. Fu received a Bachelor’s and Master’s Degree in History from Peking University in Beijing, China.

Honorary Advisor

Dr. Ho Da I, David
Prof. Ho Da I, David, M.D.

David D. Ho, M.D. is the founding Scientific Director and Chief Executive Officer of the Aaron Diamond AIDS Research Center, as well as the Irene Diamond Professor at The Rockefeller University. He has been at the forefront of AIDS research since the beginning of the epidemic. His elegant studies in the mid 1990’s unveiled the dynamic nature of HIV replication in vivo and revolutionized our basic understanding of this horrific disease. This knowledge led Dr. Ho to champion combination antiretroviral therapy that resulted in unprecedented control of HIV in patients since 1996. AIDS mortality in richer nations has declined dramatically, and a massive international effort is now underway to bring such life-saving treatment to millions in the developing world. To date over 10 million patients have benefitted from combination antiretroviral therapy. Dr. Ho has been a major driving force behind this major medical breakthrough in what is arguably the worst plague in human history. For his accomplishments, Dr. Ho has been recognized in multiple ways, including fourteen honorary doctorates and election to the National Academy of Medicine (formerly the Institute of Medicine, National Academy of Sciences). He was named Time Magazine’s Man of the Year in 1996, and was the recipient of a Presidential Medal from Bill Clinton in 2001.

Honorary Advisor

Dr. Kwok Kin Fun, Joseph
Dr. Kwok Kin Fun, Joseph


Dr. Joseph Kwok, Registered Social Worker (RSW), Ph.D., Bronze Bauhinia Star, Justice of Peace, was a former Associate Professor of the City University of Hong Kong. Dr. Kwok has intensive and extensive involvement in disability movements at global, regional and local levels.

He is a member of RI Global Executive Committee, and Vice Chair of its Social Commission;the Vice Chair of the Asian Pacific Disability Forum. He had participated in international and regional activities related to the drafting, adoption and monitoring of the UN Asia and Pacific Decade of Disabled Persons 1993-2012, A/P New Decade 2013-2022, and the UN Convention on the Rights of Persons with Disabilities.

In Hong Kong, he had served in the following positions in HKSAR Government Committees: Chairman of the Rehabilitation Advisory Committee, a member of the Women’s Commission, and a member of the Community Investment and Inclusion Fund. Dr. Kwok had served in following public bodies: Equal Opportunity Commission, Public Complaints Committee of Hospital Authority, the Governing Board of Kowloon Hospital and Eye Hospital, Admissions, Budgets and Allocation Committees of Community Chest. He is currently a Vice Chair of Hong Kong Joint Council for People with Disabilities, a Members of Voting Committee of Riding For the Disabled Association, Chairman of Fu Hong Society, and a member of Research Ethics Committee of Hospital Authority Kowloon Central and Kowloon East Clusters.

In 2006, Dr. Kwok received the Kazuo Itoga Memorial Award by the Shiga Prefecture Government of Japan in recognition of his contribution to disability work in both Hong Kong and the Region.

Honorary Advisor

Mrs. Kwok Yuen Wai Yee, Victoria, JP
Mrs. Kwok Yuen Wai Yee, Victoria, JP

M.Soc.Sc. (HKU), RSW, JP.

Mrs. Victoria Kwok, Registered Social Worker (RSW) and Justice of Peace, was former Social Services Director of The Salvation Army Hong Kong and Macau Command. She is a senior social worker and administrator of non-government organization. For many years, she intensively participated in and promoted the development of social welfare policy and planning, and services for elderly in Hong Kong. She had served in the following committees of the Hong Kong government: non-government organization representative to the Central Committee on Elderly Services, member of the Elderly Services Sub-committee in the drafting of 1991 White Paper on Social Welfare, non-government organization representative in annual reviews of Five Year Social Welfare Development Plans, member of Special Committee of Housing Authority on Elderly Housing.

She participated extensively in social welfare sector. In the Hong Kong Council of Social Service, she had served as Chairman of Elderly Division, member of the Executive Committee, member / Chairman of Committee on Agency Finance and Administration, etc. Since 1980s she was involved in planning and leading various exchanges between Hong Kong social welfare sector, and Ministry of Civil Affairs and National Aging Working Committee of Chinese Government, including regular mutual visits, social welfare development conferences, and personnel training. She served as Honorary Secretary and member of the Executive Committee of the Hong Kong Association of Gerontology for 18 years. She was actively involved in interdisciplinary collaboration to continuously raise standards of elderly services. She serves on three committees of the Association’s Residential Aged Care Accreditation Scheme (RACAS): Advisory, Steering and Accreditation. For more than ten years she fully involves in RACAS’s development, implementation, review and updating of accreditation standards, quality enhancement, and development. RACAS gained the certification of International Society for Quality in Health Care (ISQua) in 2008, and was the only Certification Scheme for RCHEs accredited by the Hong Kong Accreditation Service in 2014.

Honorary Advisor

Prof. Lee Tze Fan, Diana, JP
Prof. Lee Tze Fan, Diana, JP


Professor Diana Lee is the Professor of Nursing at the Nethersole School of Nursing, Faculty of Medicine, The Chinese University of Hong Kong. She is also the Director ofY.K. Pao Foundation Centre for Nursing Excellence in Chronic Illness Care and theDeputy Director of CUHK Jockey Club Institute of Ageing. Professor Lee was the Former Chairman of the Nursing Council of Hong Kong and is a fellow of the American Academy of Nursing.
Professor Lee's research interests lie in the areas of elderly health care and chronic illness care. She has been honored with the 'Excellent Research Award' by the Food and Health Bureau in 2007. Her research efforts are focused on promoting health-related quality of life for older people and patients with chronic illness, as well as on evaluating new initiatives for improving elderly health care services. In particular, she has conducted various studies to promote the
quality of care in nursing homes. Recently, she is investigating end-of-life issues in nursing homes and in the community. She also led the territory-wide CADENZA training programme which was a HK$73.8 million funding programme to provide gerontological education and foster positive community attitudes towards aging.

Professor Lee is dedicated to community service and has served on many government boards and councils. In recognition of her contributions to the community, she was appointed Justice of the Peace by the HKSAR Government in 2016.

Honorary Advisor

Dr. Leong Che Hung, Edward, GBM, JP
Dr. Leong Che Hung, Edward, GBM, JP


Dr. Leong is a surgeon in private practice. He is currently Chairman of Hong Kong AIDS Foundation.
Dr. Leong was an unofficial Member of the Executive Council of the Government of the Hong Kong Special Administrative Region from 2005 to 2012. He was also an elected member of the Legislative Council from 1988 to 2000. Dr. Leong has held many key posts in the public service sector, including Chairman of the Hospital Authority (2002-2004),Chairman of the Council on Human Reproductive Technology (2001-2010), Chairman of the Elderly Commission (2005-2011), Chairman of the University of Hong Kong (HKU) Council(2009-2015), Chairman of ICAC Complaints Committee (2010-2015), Chairman of Elder Academy Development Foundation (2009-2017)and Chairman of the Committee on Standard Working Hours (2013-2017).
On the professional side, Dr. Leong is the Hunterian Professor of the Royal College of Surgeons of England and a Regent of the Royal College of Surgeons of Edinburgh. Dr.Leong was the Founding President of The College of Surgeons of Hong Kong. He served as President of the Hong Kong Academy of Medicine from 2000 to 2004.

Current Position(s)
- Chairman, Hong Kong AIDS Foundation
- Hunterian Professor, Royal College of Surgeons of England
- Regent, Royal College of Surgeons of Edinburgh

Past Position(s)
- Non-official Member, Executive Council, HKSARG
- Member, Legislative Council
- Chairman, Hospital Authority
- Chairman, Council on Human Reproductive Technology
- Chairman, Elderly Commission
- Chairman, HKU Council
- Chairman, ICAC Complaints Committee
- Chairman, Elder Academy Development Foundation
- Chairman, Committee on Standard Working Hours of Hong Kong
- Founding President, College of Surgeons of Hong Kong
- President, Hong Kong Academy of Medicine

Honorary Advisor

Dr. Leung Chi Tat, Antony
Dr. Leung Chi Tat, Antony

Dr. Antony Leung graduated MBBS with distinction in Medicine from the University of Hong Kong and received postgraduate training in the Glasgow Royal Infirmary, Scotland.  After obtaining specialist qualification in Advanced Internal Medicine and Nephrology, he was admitted as a fellow of the Royal College of Physicians & Surgeons of Glasgow as well as a founding fellow of the Hong Kong College of Physician.  He had served as a clinical lecturer in the Faculty of Medicine in the Chinese University of Hong Kong and later on Hospital Chief Executive of the Haven of Hope Hospital.  He was among the first batch of specialists in Palliative Medicine in Hong Kong and is at present the Medical Superintendent of the Haven of Hope Sister Annie Skau Holistic Care Centre, a 100 beds independent hospice providing integrated End-of-Life care for the frail elders and patients with late stage chronic diseases.  He has published over 50 articles in local and international journals on case management, elderly care, palliative care, spiritual care in End-of-Life and public health administration.  He is also active in community service and was awarded the Bronze Bauhinia Star medal in 2017 by the Hong Kong SAR Government for his contribution in holistic End-of-Life care.

Honorary Advisor

Mr. Li Ho Kei, Hermes
Mr. Li Ho Kei, Hermes

Hermes Li is the Founder and Chief Investment Officer of Aspex Management, a Hong Kong based family office and investment company focused on Pan-Asian equities investing with a bottom-up fundamental investment approach.

Prior to founding Aspex Management in 2018, Mr. Li was an Executive Managing Director and Head of Asia Equities for Oz Management, one of the largest alternative asset managers globally. In his role, Mr. Li managed the OZ Asia Master Fund and oversaw Asia equities and private investments across the firm.

Prior to joining Oz Management in 2011, Mr. Li worked at Goldman, Sachs & Co. in Hong Kong as an Executive Director in the FICC division managing a capital structure trading portfolio covering equities, convertible and high-yield investments.

Mr. Li is from Hong Kong and holds a B.Sc. in Economics from the London School of Economics and Political Science.

Honorary Advisor

Prof. Lo Chung Mau, BBS, JP
Prof. Lo Chung Mau, BBS, JP

Professor Chung-Mau Lo is Hospital Chief Executive at The University of Hong Kong-Shenzhen Hospital, Chin Lan-Hong Professor and Chair of Hepatobiliary and Pancreatic Surgery as well as Director of Liver Transplantation Centre at Queen Mary Hospital. He is internationally renowned for his expertise in hepatobiliary surgery, liver cancer and liver transplantation. He has published over 460 original articles in refereed national and international journals, and authored 12 book chapters. His pioneering work in adult right lobe living donor liver transplantation has revolutionalized the practice of liver transplant world-wide and has put Hong Kong and China on the world map of liver transplant. As a result, he and his team were awarded China’s top national honor of First-class State Scientific and Technological Progress Award in 2005 and First-class Award in Research Achievements in 2013. He serves in the editorial board of top journals in the field of surgery and transplantation and was the President of the International Liver Transplantation Society and the International Society for Digestive Surgery. He has been elected as an Honorary Fellow of the American Surgical Association and the American College of Surgeons, and alsoan Honorary Member of the European Surgical Association. In recognition of his contribution to public services, Professor Lo has been appointed as Justice of Peace by the Government of Hong Kong SAR since 2012, and awarded the Bronze Bauhinia Star in 2016.

Honorary Advisor

Prof. Seto Wing Hong, BBS, SBS
Prof. Seto Wing Hong, BBS, SBS

Professor WH Seto played a key role in initiating Infection Control in Hong Kong and started the local training course for Infection Control Practitioners in 1985. He is involved extensively in Infection Control education throughout China and the region and is the Founding President of the Asia Pacific Society of Infection Control. Besides being Honorary Professor for the University of Hong Kong and the Hong Kong Polytechnic University, he is also a visiting professor for the University of New South Wales.

He was conferred honorary professorships by several universities in China including Honorary Professorship for Infection Control by the Postgraduate Military Medical College of the PLA General Hospital (301). The People’s Liberation Army of China has in addition appointed him honorary consultant for Infection control in 1999.

He is also the past Chairman of the Scientific Committee on Infection Control of the Centre for Health Protection of HKSAR Government. He has authored over a hundred and fifty research papers including the book “Infection Control for the Asian Healthcare Worker”. Many international societies had invited him to speak on Infection Control.

The WHO has also regularly assigned him as advisor for various projects in Infection Control, Antibiotics Resistance and a core group member for the WHO Hand Hygiene guideline. He is also a member of the Emergency Committee of the International Health Regulations (IHR) of the WHO, member of the Global Infection Prevention and Control Network (GIPC) and Director of WHO Collaborating Centre for Infectious Disease Epidemiology and Control, The University of Hong Kong. He is also awarded the “Bronze Bauhinia Star” in 2004 and “Silver Bauhinia Star” in 2011 from the Hong Kong Government for his work in Infection Control in Hong Kong.

He is also active in the related field of Quality Healthcare Management and is presently the President of the Asia Pacific Society of Healthcare Quality. He is a Certified Professional in Healthcare Quality (CPHQ) and was the CPHQ Examination Committee in 2000-2001. He is also a F1000 Prime Faculty Member since 2014.

Honorary Advisor

Tam, Raymond, GBS, JP
Tam, Raymond, GBS, JP

Mr. Raymond Tam, GBS and JP, has spent 30 years in the public service. He was Secretary for Constitutional and Mainland Affairs from 2011 to 2017. Before then, he was Director of the Chief Executive’s Office from 2009 to 2011, and Under Secretary for Constitutional and Mainland Affairs from 2008 to 2009. During his earlier years as a career civil servant, Raymond worked in various government departments such as the Financial Secretary’s Office, the Central Policy Unit, and Home Affairs Bureau. Raymond was also posted to the Geneva Economic and Trade Office as a member of the Hong Kong Delegation participating in the global trade negotiations conducted under the World Trade Organization. Raymond was awarded a Gold Bauhinia Star (GBS) in 2012 and was appointed as a Justices of the Peace (JP) in 2017 by the Hong Kong SAR Government. Raymond graduated from the University of Hong Kong with a Bachelor of Science degree in electrical engineering.

Senior Advisor

Prof. Grace Tang, SBS, JP
Prof. Grace Tang, SBS, JP

Professor Grace Tang is Honorary Clinical Professor in the Department of Obstetrics and Gynaecology at the University of Hong Kong, a pioneering women’s health advocate and a respected leader in medical education.

Professor Tang led the way with her research related to women’s health in Hong Kong, including the study of psychosexual issues in women and longitudinal study of menopausal symptoms, bone mineral density and bone loss in Chinese women, Chinese Medicine in the treatment of menopausal women, and the Human Papillomavirus (HPV) vaccine in the prevention of precancerous lesions of the cervix and the vulva.

She holds an MBBS (1971) and an MD (2006) from HKU, and has loyally remained at her alma mater for her entire professional career. As Dean of Medicine (1998-2001), Professor Tang successfully implemented a New Medical Curriculum, inspired by her passionate and memorable motto: “Failure is not an option.”

In 2011, she was seconded to the HKU-Shenzhen Hospital to serve as its Founding Hospital Chief Executive, to build a pilot hospital in Mainland China for healthcare reform, as well as a world-class hospital in clinical service, teaching and research.

Professor Tang has served as Chairman of the Board of the Li Ka Shing Faculty of Medicine, as founding Chairman of the Asian Medical Education Association, and has lent her leadership and service to many organisations in Hong Kong and abroad as well. She was elected President of the Hong Kong Academy of Medicine in 2005, and has made meaningful progress towards achieving Continuing Professional Development certification for medical professionals. 

Professor Tang is a Fellow of the Hong Kong Academy of Medicine, and an Honorary Fellow of the Academy of Medicine of Singapore, the Royal College of Physicians (Ireland), the American College of Physicians, the Royal Australasian College of Physicians, the Hong Kong College of Obstetricians and Gynaecologists, and the Malaysian Academy of Medicine. She received the Young Scientist Award from the Asia-Oceania Federation of Obstetricians and Gynaecologists in 1991, and the Outstanding Women Professionals and Entrepreneurs Award in 2005.

Professor Tang was made a Justice of the Peace in 2001, and presented with a Silver Bauhinia Star in 2009.

Senior Advisor

Dr. Willis Yau Sheung Mui, Carrie, SBS, MBE, JP
Dr. Willis Yau Sheung Mui, Carrie, SBS, MBE, JP

Mrs. Willis is a well-respected public administrator with a wealth of experience in education, youth services and manpower development, having served in various Government bureaus and departments, as well as public bodies in Hong Kong. She was the Executive Director of the Vocational Training Council (VTC) before her retirement in 2013.
Mrs Willis has served on numerous boards and committees in the public, commerce and industrial sectors. Currently she is the Chairman of the Committee on Professional Development of Teachers and Principals; member of the Education Commission, the Standing Committee on Language Education and Research and various committees of the Vocational Training Council She is also a Governor on the board of the Canadian International School. She is a Justice of the Peace and was awarded SBS in 2009 and MBE in 1996.

Honorary Advisor

Prof. Woo, Jean
Prof. Woo, Jean

Professor Jean Woo obtained her medical degree From Cambridge University in 1974, and joined the Medical Faculty of the Chinese University of Hong Kong in 1985, being responsible for undergraduate and postgraduate training in Geriatric Medicine. She is also Honorary Consultant of the Hospital Authority, being responsible for the development of acute, non-acute and community geriatric services in the NT East region between 1993 and 2010.
She is currently Emeritus Professor of Medicine, Henry G Leong Research Professor of Gerontology and Geriatrics, Director of the Jockey Club Institute of Aging at CUHK, the SH Ho Centre for Gerontology and Geriatrics, and the Centre for Nutritional Studies. She is actively engaged in pioneering novel models of community care of older people with the aid of technology, improving the quality of care at the end of life, strategies for healthy ageing, and healthcare training through empowerment.

Further details are available at:


Honorary Advisor

Prof. Yuen Kwok Yung, SBS, JP
Prof. Yuen Kwok Yung, SBS, JP

MBBS(HK), MD(HK), FRCS(Glas), FRCPath(UK), FRCP(Edin & Lond)
Henry Fok Professor in Infectious Diseases
Chair of Infectious Diseases, Department of Microbiology
Co-Director, State Key Laboratory of Emerging Infectious Diseases
Academician, Chinese Academy of Engineering

Professor Yuen is the Director of State Key Laboratory of Emerging Infectious Diseases at the University of Hong Kong (HKU) and the Service Director (Pathology) of Hong Kong West Cluster. He has discovered over 70 novel viruses, bacteria, fungi or parasitic species, many of which are named after HKU or Hong Kong. He played a key role in the discovery of the agent causing SARS, the SARS coronavirus and the animal reservoir, thus leading to measures that were crucial to containing the SARS outbreak. The HKSAR government has honoured his contributions with the award of a Silver Bauhinia Star in 2004. He was elected to the Chinese Academy of Engineering (Basic Medicine) in 2007.
He is one of the world’s most highly cited researchers in the field of microbiology, as ranked by the Essential Science Indicator (ISI web), and has published more than 850 papers in international peer reviewed journals, with over 28,000 citations. His field of interest is novel microbes in emerging infectious disease outbreaks.

Honorary Advisor

Dr. Zhang Nai Zi
Dr. Zhang Nai Zi

Dr. Zhang Naizi is the President of the Elderly Industry Research Centre of Shanghai Jiao Tong University, and also the general manager of Medical and Elderly Care Platform, Shanghai Zhongkangxin Industrial Development Co. Ltd, branch company of CITIC Private Equity Funds Management Co., Ltd. Dr. Zhang Naizi is the member of elderly caring industry expert committee for Ministry of Civil Affairs, specialist for evaluation of the Aged Services of Shanghai Municipal Development and Reform Commission, and the Advanced professional in the China’s undertakings for the Aged.

Dr. Zhang Naizi is the former president of Shanghai No. 1 Social Welfare Home, Shanghai No. 3 Elderly Home and also the former Hospital Chief Executive of Civil Elderly Hospital. He was frequently interviewed by mainstream media. He was often invited to speak at the national aged care services and management forums on major issues.

Dr. Zhang is the pioneer in setting up the first professional center for dementia patients in China and implementing a system of personalized attention management. Dr. Zhang led the way to innovatively create a holistic aged care model, combining four core functions of the modern senior care centres, including dementia patient care, nurse care, care-fitter and rehabilitation of geriatric diseases, promoting the integrated model of medical and aged care. Dr. Zhang persists to purse on aged care scientific research, and have frequent collaboration with various universities and organizations, including Shanghai University, Shanghai Normal University, Hua Dong Hospital, Fudan University, University of Traditional Chinese Medicine, on topics such as aging psychology, physical conditions, social works, evaluation of dementia patients care, nutrition for the aged. Dr. Zhang is also giving lectures in universities and had published numerous major articles and hosted studies and researches on various topics.

Honorary Advisor

Operating Executives

Shuo Wang

Group Chief Finance Officer

Mr. Shuo Wang is the Group Finance Controller of New Frontier Group.

He works closely with venture teams across all the industries and entities that New Frontier has invested, focusing on building the excellence of finance management in each entities that helps business to grow rapidly and sustainably.

Prior to joining New Frontier Group, Mr. Wang took charge of the Risk Control and Compliance function of Amcor China and served on the Finance & Audit Committee of Amcor APAC. In addition, he was a key member that responsible for the assessment of acquisition opportunities and post-investment integration in China. Before joining Amcor, Mr. Wang worked at Deloitte, where he led consulting services for well-known MNCs and giants in financial sector and pharmaceutical industry. He was also one of auditors to execute several IPO engagements in USA and Hong Kong.

Mr. Wang earned his Bachelor degree in Engineering from Fudan University, as well as the International Master of Business Administration degree from Sauder School of Business at University of British Columbia.

Alison Chan

Group Chief Operating Office

Ms. Alison Chan is the Managing Director of New Frontier.

Prior to joining New Frontier, Alison joined Gerson Lehrman Group as the Chief Representative in China in 2009 and was last heading the New Markets development in Asia. Prior to that, Alison founded a think-tank financial advisory practice focused on enhancing SME value via strategic planning and restructuring. Alison also worked at JP Morgan Chase in Corporate Finance division in New York focusing on high yield origination. She also worked in the finance and treasury department at GE Capital. She has over 15 years of consulting, corporate finance and operational experience working in the US, Japan, Europe and China.

Born and raised in Hong Kong, Alison graduated from The University of Hong Kong with a Bachelor in Business Administration and subsequently obtained a Master in Business Administration at Harvard Business School.

Alison is the President for the Harvard Business School Association in Hong Kong and a board member of Bring Me A Book.

Albert Xu

Co-Founder & CEO Care Alliance, New Frontier Vitality

Mr. Albert Xu is the co-founder and co-CEO of Care Alliance.
Care Alliance operates post-acute rehabilitation hospitals, pediatric rehabilitation centers, geriatric hospitals and long-term nursing facilities. It is committed to promoting modern principles and practices as well as cultivating talents across the rehabilitation and age care continuum in China.

Prior to founding Care Alliance, Mr. Xu worked at Blackstone’s Private Equity Group in Shanghai and Hong Kong, responsible for the assessment, execution and management of investment opportunities in Greater China. He was a key member executing Blackstone’s first significant healthcare transaction in China – investing over US$150m into one of China’s leading manufacturers of orthopedic implants. Before joining Blackstone, Mr. Xu worked at the investment banking division of Deutsche Bank in New York and executed over US$10B+ of M&A and financing transactions.

Mr. Xu received his Bachelor of Business Administration degree with High Distinction from Stephen M. Ross School of Business at the University of Michigan.

Shuai Yuan

Co-Founder & CEO Care Alliance, New Frontier Vitality

Mr. Shuai Yuan is the co-founder and co-CEO of Care Alliance.
Care Alliance operates post-acute rehabilitation hospitals, pediatric rehabilitation centers, geriatric hospitals and long-term nursing facilities. It is committed to promoting modern principles and practices as well as cultivating talents across the rehabilitation and age care continuum in China.

Prior to forming Care Alliance, Mr. Yuan previously worked at Morgan Stanley Private Equity Asia, leading the assessment, execution and management of healthcare investment opportunities in Asia, including privatization of public hospitals and acquisition and set-up of rehabilitation hospitals. Prior to Morgan Stanley Private Equity Asia, Mr. Yuan worked in Morgan Stanley Investment Banking Division, assisting on multiple cross-border M&A transactions in industrial and transportation sectors.

Mr. Yuan received his Bachelor of Arts degree in Economics and Political Science with Distinction from Yale University.

Serena Xie

Co-Founder & CEO - YDCare, New Frontier Vitality

Mrs. Serena Xie is the Co-Founder and Chief Executive Officer of YD Care (home healthcare start-up in China), and has 15 years of experience both in China and US in the senior living and healthcare industries.
Serena returned to China in 2010 to lead the China business of global senior living and healthcare conglomerate Emeritus Senior Living and Columbia Hospital, both part of Dan Baty’s global healthcare empire. She successfully set up the first high-end foreign senior living brand and first foreign for-profit senior living facility in China, and also systematically localized the US operating model and training program to the Chinese market.

At the same time, Serena was also responsible for making investing on behalf of Columbia Pacific Healthcare Fund in China. As part of her role, she bought and built a sizable portfolio of hospital and clinic, and successfully executed the phase I strategy in terms of market entrance and operating capabilities. In addition, she was a key member in securing the major capital investment from Singapore Sovereign Fund.

Serena earned his Bachelor degree in Finance from University of Illinois at Chicago.

Sara Li

Co-Founder & COO - YDCare, New Frontier Vitality

Mrs. Sara Li is the Co-Founder and Chief Operating Officer of YD Care (home care & home healthcare), and has over 13 years of experiences in hospital, clinic and senior living investment, management, and operations.
Prior to joining YD Care, Mrs. Li was the Director of Investment and Business Development at Columbia China Group. She executed numerous hospital and senior living investment projects, including 1 level-3 specialty hospital and 2 clinic acquisitions, 3 greenfield hospitals and senior facility development projects in Shanghai, Jiangsu and Zhejiang Provinces.

Prior to joining the Columbia China Group, Mrs. Li held senior operations and management roles at several Level-3 public hospitals, foreign hospitals and chain medical facilities in the Yangtze River Delta Region.

Over the years of diversified exposures in the healthcare industry, Mrs. Li has gained in-depth knowledge and experience in analyzing consumer purchasing behavior. In addition, she has developed strong leadership capability as well as good understandings of government policies and regulations in the fields of acquisition, new setup and operation of medical and senior living facilities.

Mrs. Li has a Master Degree with China Pharmaceutical University.

Ed Tam


Ed Tam serves as the Chief Design officer of New Frontier Group and Vice-Chairman of NF Innovation. In his capacity as the Chief Design Officer, Ed is responsible for leading the overall brand design and experience strategy of all of our portfolio companies. He is currently working on our latest acquisition of an AI company that helps enterprises unlock the value of machine learning.

Ed was most recently the Co-founder and CEO of HelloToby, where he led the product creation and roll out of the platform. In little over a year, HelloToby has become the leading marketplace for services in Asia. He continues to serve of the board of HelloToby; providing counsel in matters concerning marketing and marketplace expansion.

Prior to joining New Frontier group, Ed was a senior marketing executive at Nike China where he was responsible for the launch of the Nike Flyknit franchise and Digital Sports. He also held several leadership roles in the world’s top marketing agencies including, TBWA and Mindshare.

Ed has previously ran his own strategic design studio, Tam + Partners in Europe where he advised a portfolio of automotive, education and sports companies on their future design agendas.

He holds a Master of Arts degree in Service Design from the Royal College of Art in the UK, as well as an undergraduate degree from the London School of Economics.

Jerry Wu


Prior to serving as an Executive Director at New Frontier Health, Dr. Wu was a practitioner at the Shanghai DongHua hospital for over seven years. Dr Wu started his career as a physician in Shanghai’s Donghua hospital. And he has has a series of commercial roles in several large private entities including Fujifilm medical equipment, Far East Leasing Ltd (part of Sino Chem group), CP Pharmaceutical and Zhengda Pharmaceutical Group.
In 2005, he served as an expert of the Chinese PACS Standards Development Group for the Ministry of Health. In 2008, he participated in the preparation of the financial reform report for the Ministry of Health’s Finance and Accounting Department. From 2014 to 2015, Dr. Wu served as consultant for several investment companies such as Columbia Medical, Bosch Medical, and Cloud Health.

Dr. Wu was born and raised in Shanghai. He graduated from Shanghai Second Medical University and has a degree in EMBA from Peking University.

Henry Sze

Doctor Specialist, Greater Bay Area Healthcare

Prof. Lin Feng


Prof. Lin Feng is the Executive Director of NF Health and President and Co-Founder of Unimed Medical Group.
Prof. Lin Feng is the Chief Surgeon of the Sixth Affiliated Hospital of Sun Yat-sen University. He is engaged in gastrointestinal surgery for more than 30 years, mainly focusing on gastrointestinal cancer research. He is a well-known expert in the field of gastrointestinal tumor (gastric cancer, colon cancer, rectal cancer, and small intestine cancer).

Prof. Lin has been the vice-chairman of China Cancer Society’s Committee on Gastrointestinal Oncology, member of Standing Committee of the China Cancer Society’s Colorectal Cancer Professional Council, member of Chinese Medical Association Oncology Branch, Vice-chairman of Chinese Medical Association Surgical Nutrition Support Group, deputy director of Guangdong Medical Association, deputy director of Department of Gastroenterology Surgery, expert of Guangdong Provincial Science and technology research group, expert of Guangdong Scientific and Technological Achievements Evaluation, expert of Gastrointestinal cancer treatment norms development experts of Ministry of Health. Prof. Lin also serves as the editorial board member of Chinese Journal of Practical Surgery, Chinese Journal of Gastrointestinal Surgery, Journal of Colorectal Cancer, Journal of Intestinal parenteral nutrition, and Lingnan Journal of Modern Clinical Surgery.

Prof. Lin graduated from Sun Yat-sen University Medical School in 1982 and studied in Japan, USA, UK, Australia and other countries.

Norman Cheung

Co-Founder & CEO - Boxful, New Frontier Innovation

Mr. Norman Cheung is the Co-Founder of New Frontier and Co-Founder & CEO of Boxful Technology.

Norman is a serial entrepreneur who has founded several technology startups in the Greater China Region over the past 6 years. He has co-founded and built Boxful Technology into the largest valet storage & logistics startup in Asia in just 18 months. Norman is also a Co-Founder and serves on the board of Toby Technology, the first service marketplace of its kind in Hong Kong.

Prior to his entrepreneurial pursuits, Mr. Cheung held senior positions in the finance sector, most recently in Investment Banking at UBS in Hong Kong & London, and in Financial Services at PricewaterhouseCoopers in London.

Norman earned his Bachelor of Science degree in Management from the London School of Economics.

Jason Zheng

Co-Founder & CEO HelloToby, New Frontier Innovation

Mr. Jason Zheng is currently an Executive Director at New Frontier and Head of Product at HelloToby.
Jason works closely with the venture team at New Frontier and is involved in the sourcing and execution of investment opportunities. He currently serves as Head of Product at HelloToby – Hong Kong’s leading Marketplace for Services. He also played an instrumental role in the creation of Boxful, Asia’s largest on-demand self-storage company.

Before joining New Frontier, Jason worked in the Investment Banking Division at JPMorgan where he was involved in a number of high-profile equity transactions across Greater Asia.

Jason earned his Master in Financial Economics degree from the University of Oxford and is also an alumnus of University of British Columbia where he earned his Bachelor in Commerce.

Prince Wang

Operating Executive, New Frontier Innovation

Prince Wang is the CTO at New Frontier where he leads the long-term technology vision of New Frontier’s various portfolio companies.

Prince currently serves as the CTO for Toby, the leading Marketplace for Services in Hong Kong, where he is responsible for overseeing all technical aspects, including the software architecture, information technology and engineering of the company. Prior to his role at Toby, Mr. Wang has over 10 years of technical experience serving as the Lead Senior Software Engineer in China’s most prestigious tech companies including AliPay and Dianpin (now Meituan-Dianpin), as well as the Senior System Architect behind one of the leading transportation management software in North America.

Prince graduated from Wuhan University where he received his Master’s in Computer Science and Bachelor in Physics.

Derek Guo

Operating Executive, New Frontier Innovation

Derek Guo currently serves as Head of Operation at Toby – Hong Kong’s leading Marketplace for Services. As a founding team member of Toby, Derek has successfully led Toby’s expansion into Taiwan.Before joining Toby in 2016, Derek was trained as an engineer in the urban planning transportation sector in Canada. He gained extensive project management experiences from working in a number of large urban projects across Vancouver and Toronto.

Derek earned his Bachelor of Applied Science at the University of British Columbia.

Arthur Chan


Prior to joining New Frontier in 2016, Arthur had co-founded two tech startups in Shanghai. Arthur also has extensive experience in the IP industry within licensing negotiation and research.
Arthur earned his Bachelor of Mathematics at the University of Waterloo.